CRISPR CASE HEARD BY BOARD


According to IPWatchDog dot com, the CRISPR case has been heard:


PTAB Hears CRISPR Gene Editing Debate: On Friday, February 4, the U.S. Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) heard oral arguments in an interference proceeding about who was first to invent the use of single-guide CRISPR-Cas9 genome engineering technology in eukaryotic cells. The two teams of scientists involved are 2020 Nobel Prize in Chemistry recipients University of California, Berkeley, Professor Jennifer Doudna and her colleague Emmanuelle Charpentier, along with their teams at their respective institutions, versus the Broad Institute, led by Feng Zhang. The hearing was livestreamed here.


https://www.ipwatchdog.com/2022/02/04/barks-bites-friday-february-4-crispr-gene-editing-tech-debated-ptab-phrma-calls-deeply-concerning-trips-waiver-ustr-deadline-closes-comments-sep-draf/id=145361/

Comments

Popular posts from this blog